Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products : another face of next-generation probiotics

Autor: Fadhlaoui, K., Arnal, M. E., Martineau, M., Camponova, P., Ollivier, Bernard, O'Toole, P. W., Brugere, J. F.

Trimethylamine (TMA) and its oxide TMAO are important biomolecules involved in disease-associated processes in humans (e.g., trimethylaminuria and cardiovascular diseases). TMAO in plasma (pTMAO) stems from intestinal TMA, which is formed from variou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______932::ec57844635d17dcbfe0a12286daf9b1d
http://www.documentation.ird.fr/hor/fdi:010078949

Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease

Autor: O’toole, Paul W, Brugère, Jean-François, Borrel, Guillaume, Gaci, Nadia, Tottey, William, O’toole, Paul, Malpuech-Brugère, Corinne

Publikováno v: Gut microbes
Gut microbes, Taylor & Francis, 2014, 5 (1), pp.5-10
Gut microbes, 2014, 5 (1), pp.5-10. ⟨10.4161/gmic.26749⟩
Gut Microbes
Gut microbes, Taylor & Francis, 2014, 5 (1), pp.5-10. ⟨10.4161/gmic.26749⟩

International audience; Trimethylamine (TMA) is produced by gut bacteria from dietary ingredients. In individuals with a hereditary defect in flavin-containing monooxygenase 3, bacterial TMA production is believed to contribute to the symptoms of tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376649a3c847afa3a353eb34b4c84495
https://hal.inrae.fr/hal-02635844

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of trimethylaminuria on daily psychosocial functioning.

Autor: Roddy D; National Centre for Inherited Metabolic Disorders The Mater Misericordiae University Hospital Dublin Ireland., McCarthy P; National Centre for Inherited Metabolic Disorders The Mater Misericordiae University Hospital Dublin Ireland., Nerney D; National Centre for Inherited Metabolic Disorders The Mater Misericordiae University Hospital Dublin Ireland., Mulligan-Rabbitt J; Trinity College Dublin The University of Dublin Dublin Ireland., Smith E; Department of Clinical Chemistry Sheffield Children's Hospital Sheffield UK., Treacy EP; National Centre for Inherited Metabolic Disorders The Mater Misericordiae University Hospital Dublin Ireland.; University College Dublin Dublin Ireland.; Trinity College Dublin The University of Dublin Dublin Ireland.

Publikováno v: JIMD reports [JIMD Rep] 2020 Oct 06; Vol. 57 (1), pp. 67-75. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2021).